 | • レポートコード：QYR2104Z5472 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、皮下生物製剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（シリンジ、ウェアラブルインジェクター、自動インジェクター、インプラント）、用途別市場規模（病院薬局、小売薬局、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・皮下生物製剤の市場動向 ・企業の競争状況、市場シェア ・皮下生物製剤の種類別市場規模（シリンジ、ウェアラブルインジェクター、自動インジェクター、インプラント） ・皮下生物製剤の用途別市場規模（病院薬局、小売薬局、ドラッグストア、オンライン薬局） ・皮下生物製剤の北米市場規模2016-2027（アメリカ、カナダ） ・皮下生物製剤のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・皮下生物製剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・皮下生物製剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・皮下生物製剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Pfizer Inc.、Genentech Inc.、Novartis AG、Biogen Idec、AbbVie Inc.、F. Hoffmann-La Roche AG、Bristol-Myers Squibb、Eisai Inc.、Takeda Pharmaceuticals Ltd.、Alnylam Pharmaceuticals、Bayer AG、GlaxoSmithKline） ・結論 |
Biologics are all the pharmaceutical products developed using a biological process. Biologic products include drug manufactured from the various living organism with the help of biotechnology. Subcutaneous biologics consists of sugar, nucleic acid, protein or their combination of these substances.
Market Analysis and Insights: Global Subcutaneous Biologics Market
The global Subcutaneous Biologics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Subcutaneous Biologics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Subcutaneous Biologics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Subcutaneous Biologics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Subcutaneous Biologics market.
Global Subcutaneous Biologics Scope and Market Size
Subcutaneous Biologics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Subcutaneous Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Delivery System and by Distribution Channel in terms of revenue and forecast for the period 2016-2027.
Segment by Delivery System
Syringe
Wearable injector
Automatic injector
Implants
Segment by Distribution Channel
Hospital pharmacies
Retail pharmacies
Drug stores
Online pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Pfizer Inc.
Genentech Inc.
Novartis AG
Biogen Idec
AbbVie Inc.
F. Hoffmann-La Roche AG
Bristol-Myers Squibb
Eisai Inc.
Takeda Pharmaceuticals Ltd.
Alnylam Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Subcutaneous Biologics Market Size Growth Rate by Delivery System: 2016 VS 2021 VS 2027
1.2.2 Syringe
1.2.3 Wearable injector
1.2.4 Automatic injector
1.2.5 Implants
1.3 Market by Application
1.3.1 Global Subcutaneous Biologics Market Share by Distribution Channel: 2016 VS 2021 VS 2027
1.3.2 Hospital pharmacies
1.3.3 Retail pharmacies
1.3.4 Drug stores
1.3.5 Online pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Subcutaneous Biologics Market Perspective (2016-2027)
2.2 Subcutaneous Biologics Growth Trends by Regions
2.2.1 Subcutaneous Biologics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Subcutaneous Biologics Historic Market Share by Regions (2016-2021)
2.2.3 Subcutaneous Biologics Forecasted Market Size by Regions (2022-2027)
2.3 Subcutaneous Biologics Industry Dynamic
2.3.1 Subcutaneous Biologics Market Trends
2.3.2 Subcutaneous Biologics Market Drivers
2.3.3 Subcutaneous Biologics Market Challenges
2.3.4 Subcutaneous Biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Subcutaneous Biologics Players by Revenue
3.1.1 Global Top Subcutaneous Biologics Players by Revenue (2016-2021)
3.1.2 Global Subcutaneous Biologics Revenue Market Share by Players (2016-2021)
3.2 Global Subcutaneous Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Subcutaneous Biologics Revenue
3.4 Global Subcutaneous Biologics Market Concentration Ratio
3.4.1 Global Subcutaneous Biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Subcutaneous Biologics Revenue in 2020
3.5 Subcutaneous Biologics Key Players Head office and Area Served
3.6 Key Players Subcutaneous Biologics Product Solution and Service
3.7 Date of Enter into Subcutaneous Biologics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Subcutaneous Biologics Breakdown Data by Delivery System
4.1 Global Subcutaneous Biologics Historic Market Size by Delivery System (2016-2021)
4.2 Global Subcutaneous Biologics Forecasted Market Size by Delivery System (2022-2027)
5 Subcutaneous Biologics Breakdown Data by Distribution Channel
5.1 Global Subcutaneous Biologics Historic Market Size by Distribution Channel (2016-2021)
5.2 Global Subcutaneous Biologics Forecasted Market Size by Distribution Channel (2022-2027)
6 North America
6.1 North America Subcutaneous Biologics Market Size (2016-2027)
6.2 North America Subcutaneous Biologics Market Size by Delivery System
6.2.1 North America Subcutaneous Biologics Market Size by Delivery System (2016-2021)
6.2.2 North America Subcutaneous Biologics Market Size by Delivery System (2022-2027)
6.2.3 North America Subcutaneous Biologics Market Size by Delivery System (2016-2027)
6.3 North America Subcutaneous Biologics Market Size by Distribution Channel
6.3.1 North America Subcutaneous Biologics Market Size by Distribution Channel (2016-2021)
6.3.2 North America Subcutaneous Biologics Market Size by Distribution Channel (2022-2027)
6.3.3 North America Subcutaneous Biologics Market Size by Distribution Channel (2016-2027)
6.4 North America Subcutaneous Biologics Market Size by Country
6.4.1 North America Subcutaneous Biologics Market Size by Country (2016-2021)
6.4.2 North America Subcutaneous Biologics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Subcutaneous Biologics Market Size (2016-2027)
7.2 Europe Subcutaneous Biologics Market Size by Delivery System
7.2.1 Europe Subcutaneous Biologics Market Size by Delivery System (2016-2021)
7.2.2 Europe Subcutaneous Biologics Market Size by Delivery System (2022-2027)
7.2.3 Europe Subcutaneous Biologics Market Size by Delivery System (2016-2027)
7.3 Europe Subcutaneous Biologics Market Size by Distribution Channel
7.3.1 Europe Subcutaneous Biologics Market Size by Distribution Channel (2016-2021)
7.3.2 Europe Subcutaneous Biologics Market Size by Distribution Channel (2022-2027)
7.3.3 Europe Subcutaneous Biologics Market Size by Distribution Channel (2016-2027)
7.4 Europe Subcutaneous Biologics Market Size by Country
7.4.1 Europe Subcutaneous Biologics Market Size by Country (2016-2021)
7.4.2 Europe Subcutaneous Biologics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Subcutaneous Biologics Market Size (2016-2027)
8.2 Asia-Pacific Subcutaneous Biologics Market Size by Delivery System
8.2.1 Asia-Pacific Subcutaneous Biologics Market Size by Delivery System (2016-2021)
8.2.2 Asia-Pacific Subcutaneous Biologics Market Size by Delivery System (2022-2027)
8.2.3 Asia-Pacific Subcutaneous Biologics Market Size by Delivery System (2016-2027)
8.3 Asia-Pacific Subcutaneous Biologics Market Size by Distribution Channel
8.3.1 Asia-Pacific Subcutaneous Biologics Market Size by Distribution Channel (2016-2021)
8.3.2 Asia-Pacific Subcutaneous Biologics Market Size by Distribution Channel (2022-2027)
8.3.3 Asia-Pacific Subcutaneous Biologics Market Size by Distribution Channel (2016-2027)
8.4 Asia-Pacific Subcutaneous Biologics Market Size by Region
8.4.1 Asia-Pacific Subcutaneous Biologics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Subcutaneous Biologics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Subcutaneous Biologics Market Size (2016-2027)
9.2 Latin America Subcutaneous Biologics Market Size by Delivery System
9.2.1 Latin America Subcutaneous Biologics Market Size by Delivery System (2016-2021)
9.2.2 Latin America Subcutaneous Biologics Market Size by Delivery System (2022-2027)
9.2.3 Latin America Subcutaneous Biologics Market Size by Delivery System (2016-2027)
9.3 Latin America Subcutaneous Biologics Market Size by Distribution Channel
9.3.1 Latin America Subcutaneous Biologics Market Size by Distribution Channel (2016-2021)
9.3.2 Latin America Subcutaneous Biologics Market Size by Distribution Channel (2022-2027)
9.3.3 Latin America Subcutaneous Biologics Market Size by Distribution Channel (2016-2027)
9.4 Latin America Subcutaneous Biologics Market Size by Country
9.4.1 Latin America Subcutaneous Biologics Market Size by Country (2016-2021)
9.4.2 Latin America Subcutaneous Biologics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Subcutaneous Biologics Market Size (2016-2027)
10.2 Middle East & Africa Subcutaneous Biologics Market Size by Delivery System
10.2.1 Middle East & Africa Subcutaneous Biologics Market Size by Delivery System (2016-2021)
10.2.2 Middle East & Africa Subcutaneous Biologics Market Size by Delivery System (2022-2027)
10.2.3 Middle East & Africa Subcutaneous Biologics Market Size by Delivery System (2016-2027)
10.3 Middle East & Africa Subcutaneous Biologics Market Size by Distribution Channel
10.3.1 Middle East & Africa Subcutaneous Biologics Market Size by Distribution Channel (2016-2021)
10.3.2 Middle East & Africa Subcutaneous Biologics Market Size by Distribution Channel (2022-2027)
10.3.3 Middle East & Africa Subcutaneous Biologics Market Size by Distribution Channel (2016-2027)
10.4 Middle East & Africa Subcutaneous Biologics Market Size by Country
10.4.1 Middle East & Africa Subcutaneous Biologics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Subcutaneous Biologics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Subcutaneous Biologics Introduction
11.1.4 Abbott Laboratories Revenue in Subcutaneous Biologics Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Details
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Subcutaneous Biologics Introduction
11.2.4 Pfizer Inc. Revenue in Subcutaneous Biologics Business (2016-2021)
11.2.5 Pfizer Inc. Recent Development
11.3 Genentech Inc.
11.3.1 Genentech Inc. Company Details
11.3.2 Genentech Inc. Business Overview
11.3.3 Genentech Inc. Subcutaneous Biologics Introduction
11.3.4 Genentech Inc. Revenue in Subcutaneous Biologics Business (2016-2021)
11.3.5 Genentech Inc. Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Subcutaneous Biologics Introduction
11.4.4 Novartis AG Revenue in Subcutaneous Biologics Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 Biogen Idec
11.5.1 Biogen Idec Company Details
11.5.2 Biogen Idec Business Overview
11.5.3 Biogen Idec Subcutaneous Biologics Introduction
11.5.4 Biogen Idec Revenue in Subcutaneous Biologics Business (2016-2021)
11.5.5 Biogen Idec Recent Development
11.6 AbbVie Inc.
11.6.1 AbbVie Inc. Company Details
11.6.2 AbbVie Inc. Business Overview
11.6.3 AbbVie Inc. Subcutaneous Biologics Introduction
11.6.4 AbbVie Inc. Revenue in Subcutaneous Biologics Business (2016-2021)
11.6.5 AbbVie Inc. Recent Development
11.7 F. Hoffmann-La Roche AG
11.7.1 F. Hoffmann-La Roche AG Company Details
11.7.2 F. Hoffmann-La Roche AG Business Overview
11.7.3 F. Hoffmann-La Roche AG Subcutaneous Biologics Introduction
11.7.4 F. Hoffmann-La Roche AG Revenue in Subcutaneous Biologics Business (2016-2021)
11.7.5 F. Hoffmann-La Roche AG Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Subcutaneous Biologics Introduction
11.8.4 Bristol-Myers Squibb Revenue in Subcutaneous Biologics Business (2016-2021)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Eisai Inc.
11.9.1 Eisai Inc. Company Details
11.9.2 Eisai Inc. Business Overview
11.9.3 Eisai Inc. Subcutaneous Biologics Introduction
11.9.4 Eisai Inc. Revenue in Subcutaneous Biologics Business (2016-2021)
11.9.5 Eisai Inc. Recent Development
11.10 Takeda Pharmaceuticals Ltd.
11.10.1 Takeda Pharmaceuticals Ltd. Company Details
11.10.2 Takeda Pharmaceuticals Ltd. Business Overview
11.10.3 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Introduction
11.10.4 Takeda Pharmaceuticals Ltd. Revenue in Subcutaneous Biologics Business (2016-2021)
11.10.5 Takeda Pharmaceuticals Ltd. Recent Development
11.11 Alnylam Pharmaceuticals
11.11.1 Alnylam Pharmaceuticals Company Details
11.11.2 Alnylam Pharmaceuticals Business Overview
11.11.3 Alnylam Pharmaceuticals Subcutaneous Biologics Introduction
11.11.4 Alnylam Pharmaceuticals Revenue in Subcutaneous Biologics Business (2016-2021)
11.11.5 Alnylam Pharmaceuticals Recent Development
11.12 Bayer AG
11.12.1 Bayer AG Company Details
11.12.2 Bayer AG Business Overview
11.12.3 Bayer AG Subcutaneous Biologics Introduction
11.12.4 Bayer AG Revenue in Subcutaneous Biologics Business (2016-2021)
11.12.5 Bayer AG Recent Development
11.13 GlaxoSmithKline
11.13.1 GlaxoSmithKline Company Details
11.13.2 GlaxoSmithKline Business Overview
11.13.3 GlaxoSmithKline Subcutaneous Biologics Introduction
11.13.4 GlaxoSmithKline Revenue in Subcutaneous Biologics Business (2016-2021)
11.13.5 GlaxoSmithKline Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Subcutaneous Biologics Market Size Growth Rate by Delivery System (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Syringe
Table 3. Key Players of Wearable injector
Table 4. Key Players of Automatic injector
Table 5. Key Players of Implants
Table 6. Global Subcutaneous Biologics Market Size Growth by Distribution Channel (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Subcutaneous Biologics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Subcutaneous Biologics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Subcutaneous Biologics Market Share by Regions (2016-2021)
Table 10. Global Subcutaneous Biologics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Subcutaneous Biologics Market Share by Regions (2022-2027)
Table 12. Subcutaneous Biologics Market Trends
Table 13. Subcutaneous Biologics Market Drivers
Table 14. Subcutaneous Biologics Market Challenges
Table 15. Subcutaneous Biologics Market Restraints
Table 16. Global Subcutaneous Biologics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Subcutaneous Biologics Market Share by Players (2016-2021)
Table 18. Global Top Subcutaneous Biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Biologics as of 2020)
Table 19. Ranking of Global Top Subcutaneous Biologics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Subcutaneous Biologics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Subcutaneous Biologics Product Solution and Service
Table 23. Date of Enter into Subcutaneous Biologics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Subcutaneous Biologics Market Size by Delivery System (2016-2021) (US$ Million)
Table 26. Global Subcutaneous Biologics Revenue Market Share by Delivery System (2016-2021)
Table 27. Global Subcutaneous Biologics Forecasted Market Size by Delivery System (2022-2027) (US$ Million)
Table 28. Global Subcutaneous Biologics Revenue Market Share by Delivery System (2022-2027) & (US$ Million)
Table 29. Global Subcutaneous Biologics Market Size Share by Distribution Channel (2016-2021) & (US$ Million)
Table 30. Global Subcutaneous Biologics Revenue Market Share by Distribution Channel (2016-2021)
Table 31. Global Subcutaneous Biologics Forecasted Market Size by Distribution Channel (2022-2027) (US$ Million)
Table 32. Global Subcutaneous Biologics Revenue Market Share by Distribution Channel (2022-2027) & (US$ Million)
Table 33. North America Subcutaneous Biologics Market Size by Delivery System (2016-2021) (US$ Million)
Table 34. North America Subcutaneous Biologics Market Size by Delivery System (2022-2027) & (US$ Million)
Table 35. North America Subcutaneous Biologics Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 36. North America Subcutaneous Biologics Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 37. North America Subcutaneous Biologics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Subcutaneous Biologics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Subcutaneous Biologics Market Size by Delivery System (2016-2021) (US$ Million)
Table 40. Europe Subcutaneous Biologics Market Size by Delivery System (2022-2027) & (US$ Million)
Table 41. Europe Subcutaneous Biologics Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 42. Europe Subcutaneous Biologics Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 43. Europe Subcutaneous Biologics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Subcutaneous Biologics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Subcutaneous Biologics Market Size by Delivery System (2016-2021) (US$ Million)
Table 46. Asia-Pacific Subcutaneous Biologics Market Size by Delivery System (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Subcutaneous Biologics Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 48. Asia-Pacific Subcutaneous Biologics Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Subcutaneous Biologics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Subcutaneous Biologics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Subcutaneous Biologics Market Size by Delivery System (2016-2021) (US$ Million)
Table 52. Latin America Subcutaneous Biologics Market Size by Delivery System (2022-2027) & (US$ Million)
Table 53. Latin America Subcutaneous Biologics Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 54. Latin America Subcutaneous Biologics Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 55. Latin America Subcutaneous Biologics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Subcutaneous Biologics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Subcutaneous Biologics Market Size by Delivery System (2016-2021) (US$ Million)
Table 58. Middle East & Africa Subcutaneous Biologics Market Size by Delivery System (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Subcutaneous Biologics Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 60. Middle East & Africa Subcutaneous Biologics Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Subcutaneous Biologics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Subcutaneous Biologics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Abbott Laboratories Company Details
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories Subcutaneous Biologics Product
Table 66. Abbott Laboratories Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
Table 67. Abbott Laboratories Recent Development
Table 68. Pfizer Inc. Company Details
Table 69. Pfizer Inc. Business Overview
Table 70. Pfizer Inc. Subcutaneous Biologics Product
Table 71. Pfizer Inc. Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
Table 72. Pfizer Inc. Recent Development
Table 73. Genentech Inc. Company Details
Table 74. Genentech Inc. Business Overview
Table 75. Genentech Inc. Subcutaneous Biologics Product
Table 76. Genentech Inc. Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
Table 77. Genentech Inc. Recent Development
Table 78. Novartis AG Company Details
Table 79. Novartis AG Business Overview
Table 80. Novartis AG Subcutaneous Biologics Product
Table 81. Novartis AG Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
Table 82. Novartis AG Recent Development
Table 83. Biogen Idec Company Details
Table 84. Biogen Idec Business Overview
Table 85. Biogen Idec Subcutaneous Biologics Product
Table 86. Biogen Idec Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
Table 87. Biogen Idec Recent Development
Table 88. AbbVie Inc. Company Details
Table 89. AbbVie Inc. Business Overview
Table 90. AbbVie Inc. Subcutaneous Biologics Product
Table 91. AbbVie Inc. Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
Table 92. AbbVie Inc. Recent Development
Table 93. F. Hoffmann-La Roche AG Company Details
Table 94. F. Hoffmann-La Roche AG Business Overview
Table 95. F. Hoffmann-La Roche AG Subcutaneous Biologics Product
Table 96. F. Hoffmann-La Roche AG Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
Table 97. F. Hoffmann-La Roche AG Recent Development
Table 98. Bristol-Myers Squibb Company Details
Table 99. Bristol-Myers Squibb Business Overview
Table 100. Bristol-Myers Squibb Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
Table 101. Bristol-Myers Squibb Recent Development
Table 102. Eisai Inc. Company Details
Table 103. Eisai Inc. Business Overview
Table 104. Eisai Inc. Subcutaneous Biologics Product
Table 105. Eisai Inc. Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
Table 106. Eisai Inc. Recent Development
Table 107. Takeda Pharmaceuticals Ltd. Company Details
Table 108. Takeda Pharmaceuticals Ltd. Business Overview
Table 109. Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Product
Table 110. Takeda Pharmaceuticals Ltd. Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
Table 111. Takeda Pharmaceuticals Ltd. Recent Development
Table 112. Alnylam Pharmaceuticals Company Details
Table 113. Alnylam Pharmaceuticals Business Overview
Table 114. Alnylam Pharmaceuticals Subcutaneous Biologics Product
Table 115. Alnylam Pharmaceuticals Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
Table 116. Alnylam Pharmaceuticals Recent Development
Table 117. Bayer AG Company Details
Table 118. Bayer AG Business Overview
Table 119. Bayer AG Subcutaneous Biologics Product
Table 120. Bayer AG Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
Table 121. Bayer AG Recent Development
Table 122. GlaxoSmithKline Company Details
Table 123. GlaxoSmithKline Business Overview
Table 124. GlaxoSmithKline Subcutaneous Biologics Product
Table 125. GlaxoSmithKline Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
Table 126. GlaxoSmithKline Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Subcutaneous Biologics Market Share by Delivery System: 2020 VS 2027
Figure 2. Syringe Features
Figure 3. Wearable injector Features
Figure 4. Automatic injector Features
Figure 5. Implants Features
Figure 6. Global Subcutaneous Biologics Market Share by Distribution Channel: 2020 VS 2027
Figure 7. Hospital pharmacies Case Studies
Figure 8. Retail pharmacies Case Studies
Figure 9. Drug stores Case Studies
Figure 10. Online pharmacies Case Studies
Figure 11. Subcutaneous Biologics Report Years Considered
Figure 12. Global Subcutaneous Biologics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Subcutaneous Biologics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Subcutaneous Biologics Market Share by Regions: 2020 VS 2027
Figure 15. Global Subcutaneous Biologics Market Share by Regions (2022-2027)
Figure 16. Global Subcutaneous Biologics Market Share by Players in 2020
Figure 17. Global Top Subcutaneous Biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Biologics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Subcutaneous Biologics Revenue in 2020
Figure 19. Global Subcutaneous Biologics Revenue Market Share by Delivery System (2016-2021)
Figure 20. Global Subcutaneous Biologics Revenue Market Share by Delivery System (2022-2027)
Figure 21. North America Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Subcutaneous Biologics Market Share by Delivery System (2016-2027)
Figure 23. North America Subcutaneous Biologics Market Share by Distribution Channel (2016-2027)
Figure 24. North America Subcutaneous Biologics Market Share by Country (2016-2027)
Figure 25. United States Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Subcutaneous Biologics Market Share by Delivery System (2016-2027)
Figure 29. Europe Subcutaneous Biologics Market Share by Distribution Channel (2016-2027)
Figure 30. Europe Subcutaneous Biologics Market Share by Country (2016-2027)
Figure 31. Germany Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Subcutaneous Biologics Market Share by Delivery System (2016-2027)
Figure 39. Asia-Pacific Subcutaneous Biologics Market Share by Distribution Channel (2016-2027)
Figure 40. Asia-Pacific Subcutaneous Biologics Market Share by Region (2016-2027)
Figure 41. China Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Subcutaneous Biologics Market Share by Delivery System (2016-2027)
Figure 49. Latin America Subcutaneous Biologics Market Share by Distribution Channel (2016-2027)
Figure 50. Latin America Subcutaneous Biologics Market Share by Country (2016-2027)
Figure 51. Mexico Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Subcutaneous Biologics Market Share by Delivery System (2016-2027)
Figure 55. Middle East & Africa Subcutaneous Biologics Market Share by Distribution Channel (2016-2027)
Figure 56. Middle East & Africa Subcutaneous Biologics Market Share by Country (2016-2027)
Figure 57. Turkey Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abbott Laboratories Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
Figure 61. Pfizer Inc. Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
Figure 62. Genentech Inc. Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
Figure 63. Novartis AG Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
Figure 64. Biogen Idec Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
Figure 65. AbbVie Inc. Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
Figure 66. F. Hoffmann-La Roche AG Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
Figure 67. Bristol-Myers Squibb Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
Figure 68. Eisai Inc. Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
Figure 69. Takeda Pharmaceuticals Ltd. Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
Figure 70. Alnylam Pharmaceuticals Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
Figure 71. Bayer AG Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
Figure 72. GlaxoSmithKline Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の皮下生物製剤市場規模・現状・予測（2021年-2027年） Biologics are all the pharmaceutical products developed using a biological process. Biologic products include drug manufactured from the various living organism with the help of biotechnology. Subcutaneous biologics consists of sugar, nucleic acid, protein or their combination of these substances. M…- 世界の皮下注射市場規模・現状・予測（2021年-2027年） A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering vaccines and medications such as insulin, morphine, diacetylmorphine …
- 世界の皮下注射市場規模・現状・予測（2021年-2027年） A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering vaccines and medications such as insulin, morphine, diacetylmorphine …
- 世界の局所ドラッグデリバリーシステム市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Topical Drug Delivery System Market The global Topical Drug Delivery System market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integri…
- 世界の局所ドラッグデリバリーシステム市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Topical Drug Delivery System Market The global Topical Drug Delivery System market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integri…